Crystal structure of a constitutive active mutant of adenosine A2A receptor

IUCrJ. 2022 Mar 17;9(Pt 3):333-341. doi: 10.1107/S2052252522001907. eCollection 2022 May 1.

Abstract

The adenosine A2A receptor (A2AAR) is a prototypical member of the class A subfamily of G-protein-coupled receptors (GPCRs) that is widely distributed in various tissues and organs of the human body, and participates in many important signal-regulation processes. We have previously summarized a common activation pathway of class A GPCRs in which a series of conserved residues/motifs undergo conformational change during extracellular agonist binding and finally induce the coupling of intracellular G protein. Through this mechanism we have successfully predicted several novel constitutive active or inactive mutations for A2AAR. To reveal the molecular mechanism of mutation-induced constitutive activity, we determined the structure of a typical mutant I92N complexed with the agonist UK-432097. The mutated I92N forms a hydrophilic interaction network with nearby residues including Trp6.48 of the CWxP motif, which is absent in wild-type A2AAR. Although the mutant structure is similar overall to the previously determined intermediate-state A2AAR structure (PDB ID 3qak) [Xu, Wu, Katritch, Han, Jacobson, Gao, Cherezov & Stevens (2011). Science, 332, 322-327 ▸], molecular dynamics simulations suggest that the I92N mutant stabilizes the metastable intermediate state through the hydrophilic interaction network and favors the conformational transition of the receptor towards the active state. This research provides a structural template towards the special pharmacological outcome triggered by conformational mutation and sheds light on future structural or pharmaco-logical studies among class A GPCRs.

Keywords: G-protein-coupled receptors; adenosine A2A receptors; agonists; constitutive active mutants; crystal structures; hydrophilic interaction networks; molecular dynamics.

Grants and funding

This work was supported by the National Key Research and Development Program of China (2018YFA0507000, 2018YFA0507001), the National Nature Science Foundation of China [grants 31770898 (GS), 21704064 (QZ) and 31971178 (SZ)], the National Science and Technology Major Project of China – Innovation 2030 for Brain Science and Brain-Inspired Technology 2021ZD0203400 (QZ), and by start-up funding from Fudan University (QZ).